Immuno-Oncology: Clinical

Looking to develop custom IVD assays for your biomarker discovery? We’re hands-on with our custom assay services so that you can be hands-off and concentrate on developing ground-breaking immuno-therapies.

Be sure what you see is what you get - don’t settle for standard transcriptomics. Our IVD RNAscope™ technology enables you to identify RNA expression patterns and localization at the single cell level while maintaining the spatial and morphologic context critical for clinical relevance.

Ground-breaking biomarker discovery doesn’t have to be difficult! We understand that exosomes are the next frontier and we offer our Exosome Diagnostics services so that you can focus on your work! From GMP exosome isolation to nucleic acid and protein biomarker detection – our exosome services have got you covered.

Highly flexible assays allow you to select only the analytes you want to investigate. 

Explore the most cited ELISA kits in the market, encompassing over 600 assays across seven species. 

Optimize efficiency and conserve valuable samples with Simple Plex assays on the automated Ella platform. Ella minimizes user error and provides results in just 90 minutes.

Accelerate the path from bench to bedside. Find RUO, preclinical and GMP reagents and analytical platforms to mitigate risks and boost reproducibility in your cell therapy development and manufacturing workflow.

Avoid risks associated with viral gene engineering. Develop your CAR-T and CAR-NK cell lines faster with the non-viral transposon-based TcBuster™ gene delivery system.

ScaleReady focuses on providing scalable and cost-effective closed-workflow solutions for immune cell therapy manufacturing - including the G-Rex™ bioreactor.

Simple Western™ with Jess™ automates protein separation and analysis from crude or purified samples, enabling size- and charge-based screening of complex sample types.

Cartridge-based Simple Plex™ immunoassays on the Ella automated ELISA platform detect fragments, oligomers, and host cell proteins with low assay CVs. Up to 72 samples per run with a 60-minute time to result.

Combine the power of CE-SDS and cIEF into a single, automated platform with Maurice. Streamline cIEF and CE-SDS method development and data analysis for proteins, monoclonals, ADCs, and vaccines.